寄生性线虫 (Trichinella spiralis) 总溶解物的抗肥胖作用
Shin Ae Kang1, Hak Sun Yu1,2
1Department of Parasitology and Tropical Medicine, School of Medicine, Pusan National University, Yangsan, Republic of Korea.
Frontiers in cellular and infection microbiology
|January 23, 2024
概括
螺 (Trichinella spiralis helminth) 的溶解物显示出对抗肥胖的治疗潜力. 这些分子减少了脂肪细胞的分化,并抑制了饮食诱导模型中的肥胖症状,这表明了新的抗肥胖治疗方法.
科学领域:
- 免疫学 免疫学 免疫学
- 代谢疾病 代谢疾病
- 寄生虫学的寄生虫学
背景情况:
- 肥胖,以增加脂肪细胞大小和数量为特征,是慢性疾病的主要危险因素.
- 寄生虫调节2型免疫系统,感染与代谢综合征相反相关.
研究的目的:
- 研究虫衍生分子对高脂肪饮食 (HFD) 诱导的肥胖症的治疗潜力.
- 为了评估来自Trichinella spiralis肌肉幼虫的总溶解物的抗肥胖作用.
主要方法:
- 从T. spiralis肌肉幼虫中分离出总溶解物,用于饮食诱导的肥胖模型中.
- 通过检查M2巨细胞增强和抑制前炎性反应来评估抗肥胖作用.
- 通过测量脂质积累和脂肪生成调节剂 (PPARγ,C/EBPα,aP2) 的表达,研究了对3T3-L1前脂质细胞分化的影响.
主要成果:
- 在3T3-L1细胞中,T. spiralis总溶解物显著减少了脂质滴积累.
- 抑制了关键脂肪生成调节者的表达,包括PPARγ,C/EBPα和aP2.
- 在肥胖模型中减少了益炎性细胞因子 (IL-1β,IL-6,IFN-γ,TNF-α) 的产生.
结论:
- 在体外和体外模型中,T. spiralis总溶解酸在体外和体外模型中都显示出显著的抗肥胖作用.
- 这些发现表明T. spiralis lysate是新型抗肥胖疗法的潜在候选者.
关键词:
在M1巨细胞中.三螺旋螺旋菌 (Trichinella spiralis) 是一种螺旋螺旋菌.脂肪细胞 (adipocytes) 是一种脂肪细胞.脂质生成 (adipogenesis) 是一种肥胖 肥胖 肥胖 肥胖 肥胖 肥胖 肥胖 肥胖更多相关视频
相关概念视频
Toxoplasmosis
Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...


